← Back to Analyst Consensus 
NBP Buy
NovaBridge Biosciences
Current Price —
Implied Upside —
Analysts 7
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Apr 8, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 16, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 6, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $9 | 44% |
| Oct 24, 2025 | BTIG | reiterate | Buy → Buy | $9 | 52% |
| Oct 17, 2025 | BTIG | maintain | Buy → Buy | $9 | 52% |
| Oct 3, 2025 | Leerink Partners | initiate | — → Outperform | $9 | 51% |
| Sep 10, 2025 | BTIG | reiterate | Buy → Buy | $7 | 52% |
| Sep 9, 2025 | BTIG | initiate | — → Buy | $7 | 52% |
| Sep 8, 2025 | Needham | reiterate | Buy → Buy | $6 | 50% |
| Aug 21, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Aug 20, 2025 | Needham | maintain | Buy → Buy | $6 | 50% |
| Jul 9, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $7 | 44% |
| Jul 9, 2025 | Needham | reiterate | Buy → Buy | $5 | 50% |
| Jun 27, 2025 | Needham | maintain | Buy → Buy | $5 | 50% |
Price Target Trend
Aug 2, 2026 Oct 27, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days